NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/OBG/Gestational Diabetes
    Gestational Diabetes
    medium
    baby OBG

    A 32-year-old multigravida with gestational diabetes mellitus diagnosed at 26 weeks is on dietary management and self-monitoring of blood glucose for 2 weeks. Her fasting glucose readings are consistently 105–110 mg/dL and 2-hour postprandial values are 155–165 mg/dL, despite strict adherence to a 1800 kcal/day diet with appropriate macronutrient distribution. What is the most appropriate next step in management?

    A. Start insulin therapy with NPH insulin 10 units at bedtime; continue dietary modification
    B. Refer for continuous glucose monitoring (CGM) system
    C. Continue dietary management for another 2 weeks and repeat OGTT
    D. Initiate metformin 500 mg once daily; counsel on diet and exercise; reassess in 1 week

    Explanation

    ## Assessment of Glycemic Control Failure **Key Point:** This patient has failed lifestyle intervention. Her fasting glucose (105–110 mg/dL) and 2-hour postprandial values (155–165 mg/dL) exceed targets despite 2 weeks of optimal dietary management and SMBG. The next step is pharmacotherapy. ## Glycemic Targets in GDM (Reminder) | Parameter | Target (mg/dL) | Patient's Value (mg/dL) | Status | | --- | --- | --- | --- | | Fasting | <95 | 105–110 | **Above target** | | 2-hour postprandial | <120 | 155–165 | **Above target** | ## Choice of First-Line Pharmacotherapy in GDM **High-Yield:** In India and most international guidelines, **insulin is the preferred first-line pharmacotherapy for GDM** because: 1. Insulin does not cross the placenta (safe for fetus). 2. Rapid glycemic control is achievable (critical in pregnancy). 3. Extensive safety data in pregnancy. 4. No teratogenic risk. Metformin is an alternative (especially in obese GDM or PCOS-related GDM), but insulin is preferred as first-line in most cases, particularly when fasting hyperglycemia is present. **Clinical Pearl:** Fasting hyperglycemia (>95 mg/dL) in GDM typically reflects impaired hepatic glucose production and is best controlled with **basal insulin (NPH or long-acting insulin)**. Postprandial hyperglycemia may require rapid-acting insulin with meals. ## Insulin Initiation Strategy in GDM ```mermaid flowchart TD A[GDM with Failed Lifestyle Intervention]:::outcome --> B{Pattern of Hyperglycemia?}:::decision B -->|Fasting + Postprandial| C[Start Basal Insulin + Meal Insulin]:::action B -->|Fasting only| D[Start NPH at Bedtime]:::action B -->|Postprandial only| E[Start Rapid-Acting Insulin with Meals]:::action D --> F[Titrate by 2-4 units every 3-4 days]:::action E --> F C --> F F --> G[Target: Fasting <95, Postprandial <120 mg/dL]:::action G --> H[Continue until delivery]:::action ``` **Tip:** NPH insulin 10 units at bedtime is a reasonable starting dose for fasting hyperglycemia. Titration is performed by 2–4 units every 3–4 days based on fasting glucose readings. Rapid-acting insulin (aspart, lispro) is added if postprandial targets are not met.

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More OBG Questions